Medical costs associated with cardiovascular events among high-risk patients with hyperlipidemia
Machaon M Bonafede,1 Barbara H Johnson,1 Akshara Richhariya,2 Shravanthi R Gandra2 1Outcomes Research, Truven Health Analytics, Cambridge, MA, USA; 2Global Health Economics, Amgen, Thousand Oaks, CA, USA Objectives: This study descriptively examined acute and longer term direct medical costs associa...
Saved in:
Main Authors: | Bonafede MM (Author), Johnson BH (Author), Richhariya A (Author), Gandra SR (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patient-level costs of major cardiovascular conditions: a review of the international literature
by: Nicholson G, et al.
Published: (2016) -
Short- and longer-term health-care resource utilization and costs associated with acute ischemic stroke
by: Johnson BH, et al.
Published: (2016) -
Risk of Cardiovascular Events and Medical Cost of Dapagliflozin and Dipeptidyl Peptidase-4 Inhibitors
by: Jong-Mi Seong, et al.
Published: (2021) -
Cost-effectiveness of rosuvastatin in comparison with generic atorvastatin and simvastatin in a Swedish population at high risk of cardiovascular events
by: Gandhi SK, et al.
Published: (2012) -
Health care-resource utilization before and after natalizumab initiation in multiple sclerosis patients in the US
by: Bonafede MM, et al.
Published: (2013)